Plasma SARS-CoV-2 RNA Levels in Critically Ill COVID-19 Patients

Completed

• Conditions: ARDS Due to Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2; COVID-19 Pneumonia

• Registration Number: NCT05115045
• Lead Sponsor: Hopital of Melun

Brief Summary

Retrospective, observationnal study. Evaluation of the association between plasmatic SARS-CoV-2 RNA and day 60 mortality in ICU adult COVID-19 patients.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-11-09
• Study First Submitted: 2021-11-09
• Study First Submitted QC: 2021-11-09
• Study First Posted: 2021-11-10
• Primary Completion: 2021-12-31
• Study Completion: 2022-03-01
• Status Verified: 2023-03
• Last Update Submitted: 2023-03-31
• Last Update Posted: 2023-04-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 122

Inclusion Criteria

• age above 18 years
• in ICU hospitalization
• COVID-19 related pneumonia confirmed by PCR

Exclusion Criteria

• plasmatic SARS-COV-2 RNA quantification not available
• patient's refusal to participate

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Day 60 mortality	60 days	Association between plasmatic SARS-CoV-2 RNA level and mortality

Trial Locations

Locations (1)

Groupe Hospitalier Sud Ile de France, Hôpital de Melun-Sénart; 🇫🇷 Melun, France